| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nuvectis Pharma, Inc. | Int. Principal Financial Off. | Common Stock | 25,584 | $283,471 | $11.08 | 08 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BVXV | BiondVax Pharmaceuticals Ltd. | 01 Jan 2023 | 0 | $0 | 3 | Chief Financial Officer | 03 Jan 2023, 14:16 |
| NVCT | Nuvectis Pharma, Inc. | 08 Feb 2022 | 0 | $0 | 3 | Int. Principal Financial Off. | 08 Feb 2022, 08:24 |